Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Jan 20;7(1):659-81.
doi: 10.3390/nu7010659.

Casein-derived lactotripeptides reduce systolic and diastolic blood pressure in a meta-analysis of randomised clinical trials

Affiliations
Review

Casein-derived lactotripeptides reduce systolic and diastolic blood pressure in a meta-analysis of randomised clinical trials

Ágnes A Fekete et al. Nutrients. .

Abstract

There is an urgent need to treat individuals with high blood pressure (BP) with effective dietary strategies. Previous studies suggest a small, but significant decrease in BP after lactotripeptides (LTP) ingestion, although the data are inconsistent. The study aim was to perform a comprehensive meta-analysis of data from all relevant randomised controlled trials (RCT). Medline, Cochrane library, EMBASE and Web of Science were searched until May 2014. Eligibility criteria were RCT that examined the effects of LTP on BP in adults, with systolic BP (SBP) and diastolic BP (DBP) as outcome measures. Thirty RCT met the inclusion criteria, which resulted in 33 sets of data. The pooled treatment effect for SBP was -2.95 mmHg (95% CI: -4.17, -1.73; p < 0.001), and for DBP was -1.51 mmHg (95% CI: -2.21, -0.80; p < 0.001). Sub-group analyses revealed that reduction of BP in Japanese studies was significantly greater, compared with European studies (p = 0.002 for SBP and p < 0.001 for DBP). The 24-h ambulatory BP (AMBP) response to LTP supplementation was statistically non-significant (p = 0.101 for SBP and p = 0.166 for DBP). Both publication bias and "small-study effect" were identified, which shifted the treatment effect towards less significant SBP and non-significant DBP reduction after LTP consumption. LTP may be effective in BP reduction, especially in Japanese individuals; however sub-group, meta-regression analyses and statistically significant publication biases suggest inconsistencies.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Overall change in SBP (mmHg) after LTP supplementation. HN, high-normotensives; MH, mild-hypertensives; 0.000 refers to p<0.001. Weighted mean difference (95% CI), random effects model. Q = 141.01, df = 32, p < 0.001, I2 = 77%.
Figure 2
Figure 2
Overall change in DBP (mmHg) after LTP supplementation. HN, high-normotensives; MH, mild-hypertensives; 0.000 refers to p<0.001. Weighted mean difference (95% CI), random effects model. Q = 62.13, df = 32, p = 0.001, I2 = 49%.

References

    1. World Health Organisation (WHO) Cardiovascular Diseases (CVDs) Fact Sheet No 317 Internet. [(accessed on 21 January 2012)]. Available online: http://www.who.int/mediacentre/factsheets/fs317/en/index.html.
    1. World Health Organisation (WHO) Global Health Risk: Mortality and Burden of Disease Attributable to Selected Major Risks. [(accessed on 21 January 2012)]. Available online: http://www.who.int/healthinfo/global_burden_disease/GlobalHealthRisks_re....
    1. Appel L., Brands M., Daniels S., Karanja N., Elmer P., Sacks F. Dietary approaches to prevent and treat hypertension: A scientific statement from the American Heart Association. Hypertension. 2006;47:296–308. doi: 10.1161/01.HYP.0000202568.01167.B6. - DOI - PubMed
    1. Whitworth J. World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J. Hypertens. 2003;21:1983–1992. doi: 10.1097/00004872-200311000-00002. - DOI - PubMed
    1. Korhonen H., Pihlanto A. Bioactive peptides: Production and functionality. Int. Dairy J. 2006;16:945–960. doi: 10.1016/j.idairyj.2005.10.012. - DOI

MeSH terms